Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Circulating Myeloid Derived Suppressor Cells (MDSC) That Accumulate in Premalignancy Share Phenotypic and Functional Characteristics With MDSC in Cancer.

Ma P, Beatty PL, McKolanis J, Brand R, Schoen RE, Finn OJ.

Front Immunol. 2019 Jun 19;10:1401. doi: 10.3389/fimmu.2019.01401. eCollection 2019.

2.

Anti-MUC1 Antibody in Nipple Aspirate Fluids Correlates with Tumor Aggressiveness in Breast Cancer: A Feasibility Study.

Menekse E, McKolanis J, Finn OJ, McAuliffe PF, Johnson R, Soran A.

Dis Markers. 2015;2015:179689. doi: 10.1155/2015/179689. Epub 2015 Nov 29.

3.

MUC1 vaccine for individuals with advanced adenoma of the colon: a cancer immunoprevention feasibility study.

Kimura T, McKolanis JR, Dzubinski LA, Islam K, Potter DM, Salazar AM, Schoen RE, Finn OJ.

Cancer Prev Res (Phila). 2013 Jan;6(1):18-26. doi: 10.1158/1940-6207.CAPR-12-0275. Epub 2012 Dec 17.

4.

Mumps and ovarian cancer: modern interpretation of an historic association.

Cramer DW, Vitonis AF, Pinheiro SP, McKolanis JR, Fichorova RN, Brown KE, Hatchette TF, Finn OJ.

Cancer Causes Control. 2010 Aug;21(8):1193-201. doi: 10.1007/s10552-010-9546-1. Epub 2010 Jun 18.

5.

Anti-MUC1 antibodies and ovarian cancer risk: prospective data from the Nurses' Health Studies.

Pinheiro SP, Hankinson SE, Tworoger SS, Rosner BA, McKolanis JR, Finn OJ, Cramer DW.

Cancer Epidemiol Biomarkers Prev. 2010 Jun;19(6):1595-601. doi: 10.1158/1055-9965.EPI-10-0068. Epub 2010 May 25.

6.

A phase I/II study of a MUC1 peptide pulsed autologous dendritic cell vaccine as adjuvant therapy in patients with resected pancreatic and biliary tumors.

Lepisto AJ, Moser AJ, Zeh H, Lee K, Bartlett D, McKolanis JR, Geller BA, Schmotzer A, Potter DP, Whiteside T, Finn OJ, Ramanathan RK.

Cancer Ther. 2008;6(B):955-964.

7.

Incessant ovulation, mucin 1 immunity, and risk for ovarian cancer.

Terry KL, Titus-Ernstoff L, McKolanis JR, Welch WR, Finn OJ, Cramer DW.

Cancer Epidemiol Biomarkers Prev. 2007 Jan;16(1):30-5.

8.
9.

Conditions associated with antibodies against the tumor-associated antigen MUC1 and their relationship to risk for ovarian cancer.

Cramer DW, Titus-Ernstoff L, McKolanis JR, Welch WR, Vitonis AF, Berkowitz RS, Finn OJ.

Cancer Epidemiol Biomarkers Prev. 2005 May;14(5):1125-31.

10.
11.

Phase I study of a MUC1 vaccine composed of different doses of MUC1 peptide with SB-AS2 adjuvant in resected and locally advanced pancreatic cancer.

Ramanathan RK, Lee KM, McKolanis J, Hitbold E, Schraut W, Moser AJ, Warnick E, Whiteside T, Osborne J, Kim H, Day R, Troetschel M, Finn OJ.

Cancer Immunol Immunother. 2005 Mar;54(3):254-64. Epub 2004 Sep 14.

PMID:
15372205
12.

Mucins in gastrointestinal cancers.

Turner MS, McKolanis JR, Ramanathan RK, Whitcomb DC, Finn OJ.

Cancer Chemother Biol Response Modif. 2003;21:259-74. Review.

PMID:
15338749
13.

Analysis of the frequency of MHC-unrestricted MUC1-specific cytotoxic T-cells in peripheral blood by limiting dilution assay.

McKolanis JR, Finn OJ.

Methods Mol Biol. 2000;125:463-70. Review. No abstract available.

PMID:
10820782
14.

Lymphocyte subsets in relapsing-remitting multiple sclerosis: a longitudinal study of B lymphocytes and T lymphocytes.

Scott TF, McKolanis J, Rothfus W, Cottington E.

Neurol Res. 1994 Oct;16(5):385-8.

PMID:
7870278
15.
16.

Pharmacokinetics of recombinant interleukin-2 in children with malignancies: a Pediatric Oncology Group study.

Pais RC, Ingrim NB, Garcia ML, Abdel-Mageed A, McKolanis J, Ingrim ME, Hnath RS, Ziegler K, Ragab AH.

J Biol Response Mod. 1990 Oct;9(5):517-21.

PMID:
2254763
17.

A phase I study of interleukin-2 in children with cancer and evaluation of clinical and immunologic status during therapy. A Pediatric Oncology Group Study.

Nasr S, McKolanis J, Pais R, Findley H, Hnath R, Waldrep K, Ragab AH.

Cancer. 1989 Aug 15;64(4):783-8.

PMID:
2787201
18.

Production and characterization of monoclonal antibodies to human myeloperoxidase.

Zaki SR, Chan WC, McKolanis J, Austin GE.

Clin Immunol Immunopathol. 1989 Mar;50(3):283-97.

PMID:
2537163
19.

Uridine-responsive hypogammaglobulinemia and congenital heart disease in a patient with hereditary orotic aciduria.

Alvarado CS, Livingstone LR, Jones ME, Ravielle A, McKolanis J, Elsas LJ.

J Pediatr. 1988 Nov;113(5):867-71. No abstract available.

PMID:
3183846
20.
21.

Characterization of human myelomonocytic antigens using monoclonal antibodies.

McKolanis JR, Finn OJ, Metzgar RS.

Prog Clin Biol Res. 1983;133:145-56. No abstract available.

PMID:
6622491
22.
23.

Protein-A antibody-binding TPAAB) technique for detection of tumor-associated membrane antigen (TAMA) of Lewis lung carcinoma.

Veltri RW, McKolanis JR, Rockoff SD, McIntire KR.

Int J Cancer. 1980 Jan 15;25(1):141-5.

PMID:
7399741

Supplemental Content

Loading ...
Support Center